✦ LIBER ✦

Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis of randomized studies

✍ Scribed by Mörth, Charlott; Valachis, Antonis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doublet Versus Single Cytotoxic Agent as

✍ Qi, Wei-Xiang; Tang, Li-na; He, Ai-na; Shen, Zan; Lin, Feng; Yao, Yang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 465 KB

A phase II study testing paclitaxel as s

✍ Sculier, J.P.; Berghmans, T.; Lafitte, J.J.; Richez, M.; Recloux, P.; Van Cutsem 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 98 KB

A randomized phase III study of the doce

✍ Athanasios G Pallis; Sophia Agelaki; Athina Agelidou; Ioannis Varthalitis; Kosta 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 359 KB

Gefitinib Compared with Systemic Chemoth

✍ F. Wang; L.D. Wang; B. Li; Z.X. Sheng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 835 KB

The safety and efficacy of EGFR TKIs mon

✍ Liu, Shan; Wang, Deqiang; Chen, Bo; Wang, Yan; Zhao, Weihong; Wu, Jianqing 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 288 KB

The safety and efficacy of gefitinib ver

✍ Chang, Chia-Hsuin; Chen, Kuan-Yu; Young-Xu, Yinong; Kurth, Tobias; Orav, E. John 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 362 KB